Literature DB >> 20708370

AFP and hepatoma staging.

V Wiwanitkit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20708370     DOI： 10.1016/j.ejso.2010.07.009

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN： 0748-7983            Impact factor:   4.424


× No keyword cloud information.
  2 in total

1.  Hepatoma-Targeted Radionuclide Immune Albumin Nanospheres: (131)I-antiAFPMcAb-GCV-BSA-NPs.

Authors:  Mei Lin; Junxing Huang; Dongsheng Zhang; Xingmao Jiang; Jia Zhang; Hong Yu; Yanhong Xiao; Yujuan Shi; Ting Guo
Journal:  Anal Cell Pathol (Amst)       Date:  2016-02-15       Impact factor: 2.916

2.  A combination hepatoma-targeted therapy based on nanotechnology: pHRE-Egr1-HSV-TK/(131)I-antiAFPMcAb-GCV/MFH.

Authors:  Mei Lin; Junxing Huang; Xingmao Jiang; Jia Zhang; Hong Yu; Jun Ye; Dongsheng Zhang
Journal:  Sci Rep       Date:  2016-09-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.